DiNovA Capital
VC Fund
Shenzhen, China
DiNovA Capital is a VC fund in Shenzhen focused on Medical and Health Care. Founded in 2011, DiNovA Capital is a leading venture capital firm dedicated to healthcare industry and consists of talented and globally connected professionals who have extensive experience in investment management, private equity, venture capital and incubation. Our team leverages its knowledge, connections, network and support to assist ourpartners and portfolio companies in seizing new opportunities for substantial growth. DiNovA Capital currently manages five USD and RMB funds.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries DiNovA Capital invests in
Stages DiNovA Capital invests in
Countries DiNovA Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Eric Zi
|
|||
Investment Focus
Industry
- Medical 3 (100%)
- Health Care 2 (67%)
- Biotechnology 2 (67%)
- Robotics 1 (33%)
- Medical Device 1 (33%)
Stage
- Series E 2 (67%)
- Series D 1 (33%)
Country
- United States 2 (67%)
- China 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Eric Zi
General Partner
|
General Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sonendo
|
Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System. | $35M / Series E / Dec 13, 2016 | |
AngioSlide
|
Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now captureand remove embolic particles during angioplasty procedures. | $3M / Series E / May 01, 2015 | |
Surgerii Technology
|
Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design andintegration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China. | $100M / Series D |
Co-Investors
Agate Medical Investments
1 deal together
Fjord Ventures
1 deal together
Hefei Industry Investment Group
1 deal together
Loyal Valley Capital
1 deal together
Meritech Capital Partners
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does DiNovA Capital invest in?
DiNovA Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series E and Series D stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact DiNovA Capital?
Public channels for DiNovA Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DiNovA Capital?
The team at DiNovA Capital includes Eric Zi (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
